Figure 1From: A novel model-based approach for dose determination of glycopyrronium bromide in COPD Trough FEV 1 dose−response results at 24 hours at steady-state (modified intent-to-treat population). Model average placebo-adjusted values for OD and BID dosing regimens, with 90% confidence limits (red and blue shaded areas, respectively). FEV1: forced expiratory volume in one second; OD: once daily; BID: twice daily.Back to article page